Related Experiment Video
Updated: Jun 18, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Published on: April 30, 2020
Tuberculosis treatment adherence and fatality in Spain
Joan A Caylà1, Teresa Rodrigo, Juan Ruiz-Manzano
1Programa Integrado de Investigación en Tuberculosis (PII TB) de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Spain. jcayla@aspb.es
Tuberculosis treatment adherence is crucial for control. Factors like immigration status, living situation, and prior treatment impact adherence, while age, HIV infection, and drug use increase mortality risk, necessitating targeted interventions and closer monitoring.
Area of Science:
- Pulmonology
- Infectious Diseases
- Public Health
Background:
- Adherence to long tuberculosis (TB) treatment is vital for TB control.
- Patient dropout and mortality remain significant challenges in TB management.
- Identifying factors associated with treatment default and death is essential.
Purpose of the Study:
- To identify factors associated with defaulting from or dying during antituberculosis treatment.
- To analyze predictors of treatment completion and case fatality.
- To inform targeted interventions for improved TB treatment outcomes.
Main Methods:
- Prospective study of 1490 TB cases diagnosed between 2006-2007.
- Logistic regression analysis to determine predictive factors for treatment completion and fatality.
- Calculation of odds ratios (OR) and 95% confidence intervals (CI) for identified risk factors.
Main Results:
- Treatment completion rate was 93.5%.
- Poor adherence associated with immigration, living alone, institutional residency, prior treatment, injecting drug use (IDU), and comprehension difficulties.
- Case fatality rate was 1.8%, associated with older age, retirement, HIV infection, comprehension difficulties, IDU, and Directly Observed Therapy (DOT).
Conclusions:
- Immigrants, individuals living alone, institutional residents, previously treated patients, and IDUs require targeted Directly Observed Therapy (DOT) due to poor adherence.
- Stricter monitoring is needed for elderly patients, retired individuals, HIV-infected patients, IDUs, and those with comprehension difficulties to reduce fatality.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...